This is supported by the findings of the ameliorating effect of 5-HT1A receptors activation on antipsychotic-induced extrapyramidal side effects (EPS) and motor disabilities in animal models of Parkinson's disease in a study by 39. The gene discussed is HTR1A; the disease is Parkinson disease.